Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H25NO |
Molecular Weight | 295.4186 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(C1CCN(CCC2=CC=CC=C2)CC1)C3=CC=CC=C3
InChI
InChIKey=AXNGJCOYCMDPQG-UHFFFAOYSA-N
InChI=1S/C20H25NO/c22-20(18-9-5-2-6-10-18)19-12-15-21(16-13-19)14-11-17-7-3-1-4-8-17/h1-10,19-20,22H,11-16H2
Molecular Formula | C20H25NO |
Molecular Weight | 295.4186 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/7714223
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7714223
Glemanserin is a selective antagonist of the 5-HT2A receptor. It was tested in a clinical trial, in patients with generalized anxiety disorder, however, it did not demonstrate significant anxiolytic effects.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P28223 Gene ID: 3356.0 Gene Symbol: HTR2A Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/19889890 |
1.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
The role of serotonin(2) receptors in mediating cocaine-induced convulsions. | 2000 Apr |
|
Role of the serotonin 5-HT(2A) receptor in learning. | 2003 Sep-Oct |
|
Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice. | 2007 Oct |
|
The time-course for up- and down-regulation of the cortical 5-hydroxytryptamine (5-HT)2A receptor density predicts 5-HT2A receptor-mediated behavior in the rabbit. | 2007 Oct |
|
Role of spinal serotonin 5-HT2A receptor in 2',3'-dideoxycytidine-induced neuropathic pain in the rat and the mouse. | 2008 Jul |
|
Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. | 2008 Nov |
|
Serotonin 5-HT2A receptor involvement and Fos expression at the spinal level in vincristine-induced neuropathy in the rat. | 2008 Nov 30 |
|
Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT). | 2010 Feb |
|
LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor. | 2010 Feb |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7714223
In a clinical trial, glemanserin was given at a dose of 32 mg thrice daily.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1704984
Glemanserin (10(-7)-10(-6) M was incubated with guinea pig papillary muscle and dog Purkinje fiber. At that concentrations, the drug increased the action potential duration in both tissues with a maximum effective concentration of 10(-6) to 3 x 10(-6) M.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:51:13 GMT 2023
by
admin
on
Fri Dec 15 15:51:13 GMT 2023
|
Record UNII |
X96LS7MC5Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66885
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Glemanserin
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
PRIMARY | |||
|
132553-86-7
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
PRIMARY | |||
|
6990
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
PRIMARY | |||
|
Z-62
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
PRIMARY | |||
|
SUB07912MIG
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
PRIMARY | |||
|
C066169
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
PRIMARY | |||
|
100000080401
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
PRIMARY | |||
|
71781
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
PRIMARY | |||
|
X96LS7MC5Z
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
PRIMARY | |||
|
C95216
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL18972
Created by
admin on Fri Dec 15 15:51:13 GMT 2023 , Edited by admin on Fri Dec 15 15:51:13 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
ENANTIOMER -> RACEMATE |
|
||
|
ENANTIOMER -> RACEMATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|